Results 51 to 60 of about 7,708 (214)

Management of prolactinoma during pregnancy and postpartum

Journal of Integrated Health Sciences, 2015
Prolactinoma is classified as microprolactinoma when it measures
Om J Lakhani, Rishma Lakhani, M Desai, M Tripathi   +3 more
doaj   +1 more source

Aggressive giant prolactinoma: a case report

Journal of Medical Case Reports, 2022
Background Managing treatment-resistant aggressive giant prolactinoma can be challenging, as the diagnosis is often complex, and treatment beyond dopamine agonists, surgery, and radiotherapy is limited.
Marisa Khatijah Borhan, Florence Hui Sieng Tan   +1 more
doaj   +1 more source

Polycystic Ovary Syndrome and Subjective and Objective Assessments of Sleep Quality: A Systematic Review and Meta‐Analysis

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Sleep disturbances are increasingly recognized in women with polycystic ovary syndrome (PCOS), but the evidence remains inconsistent. We conducted a meta‐analysis to evaluate objective sleep abnormalities and subjective sleep complaints in women with PCOS.
Arefeh Tabashiri, Pourya Kanani, Marzieh Saei Ghare Naz, Fahimeh Ramezani Tehrani   +3 more
wiley   +1 more source

Transcriptional Profiling of Growth Hormone–Secreting Pituitary Adenoma Stem‐Like Cells: Unveiling the Significant Role of CXCR4 in Tumorigenesis and Clinical Applications

MedComm, Volume 7, Issue 9, September 2026.
Growth hormone–secreting pituitary adenomas harbor hPASCs (human pituitary adenoma stem‐like cells). Genetic profiling of hPASCs identified CXCR4 as a significant gene orchestrating a regulatory network in the self‐renewal and differentiation of hPASCs, as well as the modulation of tumor cells and the microenvironment.
LinHao Yuan, Hao Yang, BaoWang Li, Huimin Sui, Peiliang Li, Xu Wang, Jiang Li, Guijun Jia, Zhaohui Zhu, Deling Li, Wang Jia, Peng Kang   +11 more
wiley   +1 more source

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

Equine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken, H. Tyra, M. Vetter, K. Kiger, S. Rao, L. Bass   +5 more
wiley   +1 more source

Latent Class Analysis of Negative Emotion Subtypes and Their Association With Quality of Life in Patients With Pituitary Neuroendocrine Tumors

Brain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Introduction Pituitary neuroendocrine tumors (PitNETs) account for up to 15% of intracranial tumors. Patients commonly present with various emotional and cognitive impairments, including a high prevalence of anxiety and depression. Therefore, this study aimed to identify the latent subtypes of negative emotions in patients with PitNETs and ...
Lei Jin, FangYuan Yao, JinHua Yang, Jing Gong, JingHua Sheng, ShuYa Chen, Li Ji, Chen Wei   +7 more
wiley   +1 more source

Caracterización clínica y de laboratorio de los pacientes con diagnóstico de Prolactinoma en el Hospital de Especialidades Eugenio Espejo durante el periodo enero 2015 - enero 2018.

, 2018
Los prolactinomas son uno de los principales tipos de adenomas hipofisarios constituyendo hasta un 50% de dichos tumores, con un gran impacto sobre la salud de esta población, derivado de sus efectos clínicos: 1) efectos hormonales por hiperprolactinemia
Fuentes Garzón, Nubia Maribel
core   +1 more source

A case of giant prolactinoma and pituitary hemorrhage with the late recovery of pituitary function: A case report

SAGE Open Medical Case Reports, 2023
Hypogonadotropic hypogonadism is a common finding in patients who are diagnosed with a prolactinoma. It can be accompanied by the presence of other pituitary hormone deficits, including secondary adrenal insufficiency and central hypothyroidism.
Lakshmi P Menon, Dinesh Edem
doaj   +1 more source

Prolactin in high‐metabolic risk pregnancies: Associations with maternal obesity and metabolic health

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1490-1501, August 2026.
Higher maternal BMI before and during early pregnancy is associated with lower prolactin levels across gestation and a reduced prolactin rise. Prolactin in pregnancy may reflect maternal metabolic health and has potential relevance to lactation outcomes.
Kate Rassie, Simon Alesi, Adriana C. H. Neven, Taitum Mason, Eveline Jona, Stacey J. Ellery, Joanne Enticott, Aya Mousa, Anju E. Joham, David Simmons, Helena Teede, on behalf of the TOBOGM Core Investigator Group   +11 more
wiley   +1 more source

Additional file 5 of The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

, 2022
Additional file 5: Figure S4. AS events in SF3B1 mutant human prolactinoma and MRI scans of the estradiol-induced prolactinoma model. (A) Volcano plot showing the differential alternative splicing events in SF3B1 mutant vs.
Jing Guo (102972), Yulou Liu (10705962), Qiuyue Fang (9913857), Yazhuo Zhang (3703210), Dawei Wang (471687), Chuzhong Li (3703216), Yiyuan Chen (2715826), Weiyan Xie (7587713)   +7 more
core   +1 more source